{
  "cik": 1771910,
  "cik_padded": "0001771910",
  "entityName": "ADC Therapeutics SA",
  "fiscal_years": [
    {
      "accn": "0001628280-26-016491",
      "filed": "2026-03-10",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 264000.0,
        "cash": 261338000.0,
        "eps_diluted": -1.12,
        "free_cash_flow": -141438000.0,
        "net_income": -142623000.0,
        "operating_cash_flow": -141174000.0,
        "operating_income": -121499000.0,
        "revenue": 81357000.0,
        "stockholders_equity": -185834000.0,
        "total_assets": 323150000.0,
        "total_liabilities": 508984000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "operating_margin": -1.4934056073847364,
        "revenue_growth_yoy": 0.14850995948445023,
        "roa_avg2y": -0.4421527444081038,
        "roa_period_end": -0.44135231316725976,
        "roe_avg2y": 0.734269298489482
      }
    },
    {
      "accn": "0001628280-26-016491",
      "filed": "2026-03-10",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 867000.0,
        "cash": 250867000.0,
        "eps_diluted": -1.62,
        "free_cash_flow": -124702000.0,
        "net_income": -157846000.0,
        "operating_cash_flow": -123835000.0,
        "operating_income": -130654000.0,
        "revenue": 70837000.0,
        "stockholders_equity": -202642000.0,
        "total_assets": 321980000.0,
        "total_liabilities": 524622000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": 0.0183875327065183,
        "roa_avg2y": -0.4664741814699998,
        "roa_period_end": -0.4902354183489658,
        "roe_avg2y": 0.8996867973245253
      }
    },
    {
      "accn": "0001628280-26-016491",
      "filed": "2026-03-10",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3216000.0,
        "cash": 278598000.0,
        "eps_diluted": -2.94,
        "free_cash_flow": -121902000.0,
        "net_income": -240053000.0,
        "operating_cash_flow": -118686000.0,
        "operating_income": -165986000.0,
        "revenue": 69558000.0,
        "stockholders_equity": -148249000.0,
        "total_assets": 354782000.0,
        "total_liabilities": 503031000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": -0.6686262553118509,
        "roa_avg2y": -0.5677421033275349,
        "roa_period_end": -0.6766211363597928,
        "roe_avg2y": 6.978487746736824
      }
    },
    {
      "accn": "0001628280-25-015131",
      "filed": "2025-03-27",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 687000.0,
        "cash": 326441000.0,
        "eps_diluted": -2.01,
        "free_cash_flow": -138998000.0,
        "net_income": -157128000.0,
        "operating_cash_flow": -138311000.0,
        "operating_income": -123344000.0,
        "revenue": 209908000.0,
        "stockholders_equity": 79451000.0,
        "total_assets": 490859000.0,
        "total_liabilities": 411408000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "net_margin": -0.748556510471254,
        "operating_margin": -0.5876098100120053,
        "roa_period_end": -0.3201082184496974,
        "roe_avg2y": -1.3459826878022245
      }
    },
    {
      "accn": "0001628280-24-010843",
      "filed": "2024-03-13",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": 154026000.0
      },
      "period_end": "2021-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001628280-26-016491",
    "filed": "2026-03-10",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001771910.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001771910.json"
  },
  "ticker": "ADCT"
}